关注
Clare Malone
Clare Malone
Postdoctoral Fellow, Dana-Farber Cancer Institute
在 dfci.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors
T De Raedt, Z Walton, JL Yecies, D Li, Y Chen, CF Malone, O Maertens, ...
Cancer cell 20 (3), 400-413, 2011
2792011
A first-generation pediatric cancer dependency map
NV Dharia, G Kugener, LM Guenther, CF Malone, AD Durbin, AL Hong, ...
Nature genetics 53 (4), 529-538, 2021
1012021
mTOR and HDAC inhibitors converge on the TXNIP/thioredoxin pathway to cause catastrophic oxidative stress and regression of RAS-driven tumors
CF Malone, C Emerson, R Ingraham, W Barbosa, S Guerra, H Yoon, ...
Cancer Discovery 7 (12), 1450-1463, 2017
982017
Defining Key Signaling Nodes and Therapeutic Biomarkers in NF1-Mutant Cancers
CF Malone, JA Fromm, O Maertens, T DeRaedt, R Ingraham, K Cichowski
Cancer discovery 4 (9), 1062-1073, 2014
652014
Loss of RasGAP tumor suppressors underlies the aggressive nature of luminal B breast cancers
SN Olsen, A Wronski, Z Castaño, B Dake, C Malone, T De Raedt, M Enos, ...
Cancer discovery 7 (2), 202-217, 2017
632017
Selective modulation of a pan-essential protein as a therapeutic strategy in cancer
CF Malone, NV Dharia, G Kugener, AB Forman, MV Rothberg, ...
Cancer discovery 11 (9), 2282-2299, 2021
302021
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma
DY Lu, JM Ellegast, KN Ross, CF Malone, S Lin, NW Mabe, NV Dharia, ...
Nature Cell Biology 25 (2), 285-297, 2023
202023
Vincristine and bortezomib cause axon outgrowth and behavioral defects in larval zebrafish
TM Khan, N Benaich, CF Malone, RL Bernardos, AR Russell, GB Downes, ...
Journal of the Peripheral Nervous System 17 (1), 76-89, 2012
182012
Transcriptional antagonism by CDK8 inhibition improves therapeutic efficacy of MEK inhibitors
CF Malone, M Kim, G Alexe, K Engel, AB Forman, A Robichaud, ...
Cancer research 83 (2), 285-300, 2023
72023
Defining key signaling nodes and therapeutic biomarkers in NF1-mutant cancers. Cancer Discov. 2014; 4: 1062–1073. doi: 10.1158/2159-8290
CF Malone, JA Fromm, O Maertens, T DeRaedt, R Ingraham, K Cichowski
CD-14-0159.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
7
Scratching the surface of immunotherapeutic targets in neuroblastoma
CF Malone, K Stegmaier
Cancer Cell 32 (3), 271-273, 2017
62017
An economic study of the dairy enterprise in northeastern Iowa
R Buck, J Hopkins, C Malone
52017
Pharmacological targeting of the cancer epigenome
NW Mabe, JA Perry, CF Malone, K Stegmaier
Nature Cancer 5 (6), 844-865, 2024
22024
Defining a pediatric cancer dependency map
NV Dharia, C Malone, AB Iniguez, L Guenther, L Chen, G Alexe, ...
Cancer Research 78 (13_Supplement), 2352-2352, 2018
12018
The KAT module of the SAGA complex maintains the oncogenic gene expression program in MYCN-amplified neuroblastoma
CF Malone, NW Mabe, AB Forman, G Alexe, KL Engel, YJC Chen, ...
Science Advances 10 (22), eadm9449, 2024
2024
Targeting CDK8: A translatable therapeutic approach for fusion-positive aRMS
S Zhang, C Malone, B Guedes, K Engel, M Just, K Ross, A Fahs, ...
Cancer Research 84 (6_Supplement), 5960-5960, 2024
2024
CRISPR-Cas9 screens identify the nuclear export factor NXT1 as a novel therapeutic target in MYCN-amplified neuroblastoma
CF Malone, NV Dharia, G Kugener, B Paolella, M Rothberg, ...
Cancer Research 79 (13_Supplement), 2878-2878, 2019
2019
Dairy and hog farming in northeastern Iowa
R Buck, J Hopkins, C Malone
2017
Diverse approaches to developing combination therapies for NF1-mutant cancers
CF Malone
Harvard University, 2015
2015
CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN ZEBRAFISH
TM Khan, N Benaich, CF Malone, RL Bernardos, AR Russell, MJ Barresi, ...
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 16, S64-S65, 2011
2011
系统目前无法执行此操作,请稍后再试。
文章 1–20